BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 32977006)

  • 21. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
    Wu M; Wang M; Jia H; Wu P
    Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging prospects of extracellular vesicles for brain disease theranostics.
    Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
    J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicles: a rising star for therapeutics and drug delivery.
    Du S; Guan Y; Xie A; Yan Z; Gao S; Li W; Rao L; Chen X; Chen T
    J Nanobiotechnology; 2023 Jul; 21(1):231. PubMed ID: 37475025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine.
    Rosso G; Cauda V
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5924-5932. PubMed ID: 36535896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering Extracellular Vesicles for Cancer Therapy.
    Nedeva C; Mathivanan S
    Subcell Biochem; 2021; 97():375-392. PubMed ID: 33779924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advances.
    Wang Z; Mo H; He Z; Chen A; Cheng P
    Biomed Pharmacother; 2022 Sep; 153():113480. PubMed ID: 36076581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy.
    Ma Y; Dong S; Li X; Kim BYS; Yang Z; Jiang W
    Front Oncol; 2020; 10():606906. PubMed ID: 33628730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular vesicles as drug vectors for precise cancer treatment.
    Cao XH; Liang MX; Wu Y; Yang K; Tang JH; Zhang W
    Nanomedicine (Lond); 2021 Jul; 16(17):1519-1537. PubMed ID: 34011162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers.
    Moloudizargari M; Asghari MH; Goel A
    Biochem Pharmacol; 2021 Oct; 192():114714. PubMed ID: 34332957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications.
    Lian MQ; Chng WH; Liang J; Yeo HQ; Lee CK; Belaid M; Tollemeto M; Wacker MG; Czarny B; Pastorin G
    J Extracell Vesicles; 2022 Dec; 11(12):e12283. PubMed ID: 36519808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
    Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
    Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.
    Pham TC; Jayasinghe MK; Pham TT; Yang Y; Wei L; Usman WM; Chen H; Pirisinu M; Gong J; Kim S; Peng B; Wang W; Chan C; Ma V; Nguyen NTH; Kappei D; Nguyen XH; Cho WC; Shi J; Le MTN
    J Extracell Vesicles; 2021 Feb; 10(4):e12057. PubMed ID: 33643546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nature's carriers: leveraging extracellular vesicles for targeted drug delivery.
    Chen Q; Zheng Y; Jiang X; Wang Y; Chen Z; Wu D
    Drug Deliv; 2024 Dec; 31(1):2361165. PubMed ID: 38832506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.
    Sharma S; Masud MK; Kaneti YV; Rewatkar P; Koradia A; Hossain MSA; Yamauchi Y; Popat A; Salomon C
    Small; 2021 Oct; 17(42):e2102220. PubMed ID: 34216426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
    Ahmadi M; Hassanpour M; Rezaie J
    Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular vesicle-based drug delivery systems for cancer treatment.
    Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
    Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.